Stock Ratings / Materials / BCPC / dividends

CE (44) SXT (60) HXL (52) MEOH (60) ⌘ Pro Terminal →

Balchem Corporation (BCPC) Dividend Safety Gauge & 10-Year DRIP Compounder

$169.98 -0.25% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $170.31

Balchem Corporation (BCPC) earns a Roarable Rating of B (Buy) with 72/100 RQD Confidence. High-quality cash engine (36% profit margin, 14% return on capital) with steady institutional support. The company’s underlying cash engine and institutional positioning keep the composite score in the Green Buy zone.

📊 Historical Track Record: Scores of 72/100 (B) historically ranked in the Top 13% of excess returns over the next 90 days (+7.0% avg 90D alpha vs SPY • 68.7% hit rate) →

ROARABLE B • BUY Cap $5.41B

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on BCPC Below — or Connect Your Own ChatGPT / Claude

🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is BCPC stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

▼

As of 2026-11-02, Balchem Corporation (NASDAQ: BCPC) is rated B (Buy / BUY) by Roarable's 5-pillar RQD engine with a composite confidence score of 72/100 at a spot price of $169.98 (-0.25% 1D, market cap $5.41B). Pillar breakdown: Fundamental Cash Engine 16/20, Institutional 13F & Options Flow 11/20, Executive Insider Alignment 18/20, FRED Macro Regime Fit 12/20, and SEC Balance-Sheet Forensics 15/20. Across 270 tracked Materials issuers, BCPC ranks #6 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief

🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does BCPC compare to CE and SXT in the Materials sector?

▼

Within the Materials sector (Major Chemicals), BCPC carries a Roarable B (72/100 RQD), trailing P/E of 35.0x, gross margin of 35.7%, and ROIC of 14.0%. By comparison, CE (Celanese Corporation) holds a D grade (44/100 RQD, P/E N/A, ROIC -10.7%, cap $5.30B) and SXT (Sensient Technologies Corporation) posts a C- grade (60/100 RQD, P/E 41.6x, ROIC 8.8%, cap $5.60B). Among the 5-stock peer group, BCPC leads on earnings multiple (35.0x) while BCPC leads on capital efficiency (14.0% ROIC).

✓ Pre-computed one-to-many AI Quant brief

🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for BCPC?

▼

Per BCPC's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0000009326), Balchem Corporation generated $1.04B in revenue (+8.8% YoY), $154.8M in net income, and $216.6M in free cash flow against $1.69B in total assets and $0 in total debt. Key quantitative strengths: Strong cash generator (36% profit margin)—profits are backed by real money, not accounting tricks.. Primary risk factors monitored: Broader market pullbacks can still drag down strong stocks in the short run.. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief

🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $170.32 (+0.20%)🧬 Cannibal Buyback (-2.08% YoY Shares)⚙️ Cash Engine: 16/20 (B+) • 20.9% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record: Scores of 72/100 (B) historically ranked in the Top 13% of excess returns over the next 90 days (+7.0% avg 90D alpha vs SPY • 68.7% hit rate).

Audit Bucket Track Record →

RQD QUANT TACHOMETERBUY • B

2-of-3 JEV AI Jury Bullish

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw B- · Rk B

Each axis scored 0–20

12M PRICE TARGET CONE+6.3% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for BCPC)Realized 20D OHLCV Swing Band: ±4.7%

Deterministic 5-Pillar Attribution (72/100 Composite)

🔍 WHY BCPC SCORES 72/100 (B) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: SEC 10-K Forensic Risk+18/20 pts (25% of score)

Altman Z-Score 9.67 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 8/9

▲ #2 Bullish Driver: Cash Engine Quality+16/20 pts (22% of score)

SEC XBRL FY 2025 (10-K): 20.9% FCF Margin ($216.6M FCF) & 35.7% Gross Margin

▼ #1 Drag / Risk Factor: Whale & Options Positioning11/20 pts (-9 pt drag)

Put hedging (50% put share) caps near-term gamma upside (-9 pts vs max)

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade C+$168.19+1.3% Next Q

Q2 (-2Q)

Grade B-$170.42+0.1% Next Q

Q3 (-1Q)

Grade B-$170.62-0.4% Next Q

Current

Grade B$169.98+7% Hist 90D α

Trajectory: C+ (64) → B (72)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER

⚔️ Adversarial Opposing Case: Why the BCPC Bull Thesis Could Fail

Gideon Ashmere Forensic Desk →

Even with a 72/100 (B) score, BCPC faces multiple-compression risk if 35.0x trailing P/E re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.

⚠️ Forensic Kill-Switch #1

Broader market pullbacks can still drag down strong stocks in the short run.

⚠️ Forensic Kill-Switch #2

Dilution & Margin Drag: Cannibal Buyback (-2.08% YoY Shares) — any gross margin slip below 33.2% triggers an automatic RQD downgrade.

⚠️ Forensic Kill-Switch #3

Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($169.95) or 200D SMA ($169.29) invalidates the momentum regime and cuts Target Base ($180.69) toward Bear Floor ($139.38).

🎲 LIVE PREDICTION MARKET ODDS TIED TO $BCPC• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “BCPC Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”

YES 72%NO 28%Trade / Inspect Odds →

CASH DIVIDEND + BUYBACK YIELD

2.32% Total Yield

0.52% Cash ($0.88/yr) + 1.8% Buybacks

PAYOUT SAFETY SPEEDOMETER

88/100 • FORTRESS PAYOUT

FREE CASH FLOW PAYOUT RATIO

14% of FCF

8 consecutive years of payout growth

INTERACTIVE DRIP & SHAREHOLDER-YIELD COMPOUNDER (7.2% EST. ANNUAL)

$10,000 Compounded Over 10 Years → $20,042

Est. Year-10 Shareholder Yield: $465/yr

Starting Investment: $10,000

Compounding Horizon: 10 Years

$10.7K

Yr 1

$11.5K

Yr 2

$12.3K

Yr 3

$13.2K

Yr 4

$14.2K

Yr 5

$15.2K

Yr 6

$16.3K

Yr 7

$17.4K

Yr 8

$18.7K

Yr 9

$20.0K

Yr 10

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher + Cash-Flow & Quality Compounder Desk

Cash-Fortress Compounders: Auditing Free Cash Flow & Yield Safety in BCPC & A-Rated Leaders

✓12-month Bull/Base/Bear fair-value walkthrough on BCPC and its top sector peer
✓Top Roarable A-Rated cash compounders with verified executive & 13F accumulation
✓Includes nightly RQD rating-change & forensic signal email alerts

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

BCPC // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +4.86%📐 HORIZONTAL RANGE

2026-11-02O $166.3H $170.4L $166.3C $170.0VOL 196.2K

RES: $178.1SUP: $161.7SMA50: $170.0SMA200: $169.3

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

BCPC Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 BCPC Butterfly Map → + Track BCPC →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

27.0%/yr Implied 5Y Growth

vs. +8.8% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on BCPC today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for BCPC. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for BCPC today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (BCPC)

Materials Rank #6 of 270 ⚔️ CE vs BCPC Full Matrix →

1. Head-to-Head Materials Peer Comparison (BCPC vs. CE, SXT, HXL, MEOH)

Industry: Major Chemicals (67 Tracked Issuers)

Across 270 tracked Materials securities in the Roarable RQD universe, Balchem Corporation (BCPC) ranks #6 by composite RQD confidence (72/100, grade B) and #70 by equity capitalization ($5.41B). Within this direct 5-issuer industry benchmark cohort, BCPC leads on earnings valuation at 35.0x trailing P/E, while BCPC leads on capital efficiency and profitability with 14.0% ROIC and 35.7% gross margin. BCPC currently leads its immediate peer cohort in composite quantitative strength at 72/100 (B).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
BCPC ACTIVE Balchem Corporation	B	72/100	35.0x	35.7%	14.0%	-0.25%	$5.41B	Benchmark Subject
CE Celanese Corporation	D	44/100	—	20.5%	-10.7%	+2.03%	$5.30B	/ce-vs-bcpc →
SXT Sensient Technologies Corporation	C-	60/100	41.6x	33.5%	8.8%	-10.57%	$5.60B	/sxt-vs-bcpc →
HXL Hexcel Corporation	D+	52/100	55.0x	23.0%	6.2%	-2.15%	$6.02B	/hxl-vs-bcpc →
MEOH Methanex Corporation	C-	60/100	—	—	—	+14.04%	$4.86B	/meoh-vs-bcpc →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0000009326

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Balchem Corporation (BCPC) reported GAAP revenue of $1.04B (+8.8% vs. FY2024 revenue of $953.7M , and +12.4% cumulative change since FY2023) , GAAP net income of $154.8M, operating cash flow of $216.6M, and free cash flow of $216.6M (+19.0% YoY). On the balance sheet, BCPC closed FY2025 with $1.69B in total assets against $0 in total debt (Altman Z-Score: 9.67, Piotroski F-Score: 8/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$1.04B	$154.8M	$216.6M	$216.6M	$1.69B	—
FY2024 (FY)	2024-12-31	$953.7M	$128.5M	$182.0M	$182.0M	$1.58B	—
FY2023 (FY)	2023-12-31	$922.4M	$108.5M	$183.8M	$183.8M	—	—

3. BCPC Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is BCPC stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

How does BCPC compare to CE and SXT in the Materials sector?

What are the biggest fundamental strengths and SEC risk factors for BCPC?

Where is BCPC trading relative to its 50-day, 200-day, and 52-week technical levels?

BCPC last traded at $169.98 (-0.25% on volume of 249,328 shares), positioning the stock +0.02% above its 50-day simple moving average ($169.95) and +0.41% above its 200-day simple moving average ($169.29). Across its 52-week range of $147.18 to $183.90, BCPC sits at the 62.1% percentile with a 14-day RSI of 51.3 (NEUTRAL RANGE) and an implied next-earnings move of ±4.7% ($161.99 to $177.97).

BCPC Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

Does BCPC pay a dividend and is it safe?

Balchem Corporation (BCPC) offers a 0.52% cash dividend yield ($0.88 annualized) and 2.32% total shareholder yield including buybacks. Roarable rates its payout coverage as FORTRESS PAYOUT.

Direct Sub-Reports: BCPC RQD Cockpit BCPC 12M Forecast BCPC Earnings & Move BCPC Dividends & DRIP BCPC Insiders & 13F BCPC Whale Options BCPC Profit Sankey BCPC News & Why

Sector Peer Dials

Sensient Technologies Corporation

Perimeter Solutions SA

BCPC Core Snapshot

Market Cap $5.41B

Trailing / Fwd P/E 35.0x / 32.6x

Gross Profit Margin 35.7%

Return on Capital (ROIC) 14.0%

Free Cash Flow Yield 4.00%

12M Base Price Target $180.69

FREE TRADER TOOLS

Own BCPC Alongside Other Stocks? Run a 30-Second Crash X-Ray

Drop 3–5 tickers into our live Portfolio X-Ray to spot hidden accounting time-bombs and see your composite RQD dial.

⚡ X-Ray My Portfolio With BCPC → 🏆 Trade BCPC in $100K Prop Arena →

BCPC Wire

Why It Moved →

Peer / Ecosystem Wire Yahoo Finance • 8h ago

Update: Balchem Shares Rise After Q3 Beat

Direct Company Event Seeking Alpha • 11h ago

Balchem: Record Sales, Great Fundamentals, Priced Fully, Hold (NASDAQ:BCPC)

Direct Company Event ChartMill • 14h ago

BCPC Stock Price, Quote & Chart

Direct Company Event marketscreener.com • 17h ago

Earnings Flash (BCPC) Balchem Corporation Posts Q3 Adjusted EPS $1.57 per Share, vs. FactSet Est of $1.54

Peer / Ecosystem Wire Stock Titan • 20h ago

Quarterly sales and profit set records at Balchem. Sales reached $290.7 million.

ROARABLE RATING BRIEF • RQD 72/100 (B) ✓ STAGE-C NUMBER FIREWALL VERIFIED

BCPC — Balchem Corporation: What the Facts Mean to a Prospective Investor

Engine: anthropic/claude-haiku-5.5

As of: 2026-11-02T15:20:17Z

Roarable Rating Brief: What This Means to a Prospective Investor

Per the Roarable RQD rating, BCPC scores 72 out of 100 with a letter grade of B and a verdict label of "Roarable Buy — Good Risk/Reward." The five pillars are: Fundamental Cash Engine 16/20 (ROIC 14%; FCF yield 4%), Whale 13F Flow 11/20 (institutional accumulation and options positioning), Insider Conviction 15/20 (SEC Form 4 and Congressional PTR cluster flow), Macro Regime Fit 12/20 (Beta 1.0; sector sensitivity), and Forensic Balance Sheet 18/20 (Altman Z 9.67; Piotroski F 8/9; Debt/Equity 0.5).

For a prospective investor, the strongest pillar is the forensic balance sheet, which indicates low financial-distress risk per the rating's inputs. The cash engine pillar is solid but not exceptional, and the 4% FCF yield alongside a 35x trailing P/E implies the market is pricing in substantial future growth; this is a valuation tradeoff rather than a clear discount. The whale-flow pillar (11/20) is the weakest, suggesting institutional positioning is less conviction-driven than the other signals. Insider conviction at 15/20 is moderately supportive. The macro fit score of 12/20 with a beta of 1.0 indicates market-like sensitivity to broad moves. Upside drivers flagged in the sources include reported record quarterly results; the principal valuation risk is the premium multiple relative to the cash yield. This is an analytical summary, not personalized advice.

Snapshot

Price	Market Cap	P/E (TTM)	Forward P/E	EV/EBITDA	EPS (TTM)	Dividend Yield	Beta	52-Wk Range	ROIC %
$170.4	$5.41B	35	32.6	25.5	4.87	0.52%	1.0	$147.18 - $183.9	14%

Financial Trend

Period	Revenue	Operating Income	Net Income	EPS	FCF	Cash	Debt
FY 2025	$1037.2M	$209.3M	$154.8M	N/A	$216.6M	$74.6M	N/A
FY 2024	$953.7M	$182.9M	$128.5M	N/A	$182.0M	$49.5M	N/A
FY 2023	$922.4M	$159.2M	$108.5M	N/A	$183.8M	N/A	N/A

Per the SEC financials, revenue, operating income, and net income rose across the three reported periods. Per the market data, ROIC is 14% and the forensic pillar cites an Altman Z-Score of 9.67, a Piotroski F-Score of 8/9, and Debt/Equity of 0.5. Reported debt values are Not available in source data, so the balance-sheet posture rests on the rating's forensic inputs rather than the period-level debt figures.

Open Questions

What are the company's specific products, end markets, and customer concentration?
What are reported debt levels and EPS for each fiscal year, given that these fields are N/A or absent?
Does the Q3 beat extend into forward guidance, and how much of the 35x multiple reflects expected growth?
What are the underlying drivers of institutional and insider flow, given the whale-flow pillar scores lowest?
What upstream raw-material and downstream customer dependencies exist within Major Chemicals?

BCPC Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for Balchem Corporation (BCPC) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to BCPC Debate Forum (3) ↓

🟢 CATALYST Yahoo Finance • 8h ago

Update: Balchem Shares Rise After Q3 Beat

Yahoo Finance report covering Balchem Corporation (BCPC) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟢 CATALYST Seeking Alpha • 11h ago

Balchem: Record Sales, Great Fundamentals, Priced Fully, Hold (NASDAQ:BCPC)

Seeking Alpha report covering Balchem Corporation (BCPC) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE ChartMill • 14h ago

BCPC Stock Price, Quote & Chart

ChartMill report covering Balchem Corporation (BCPC) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE marketscreener.com • 17h ago

Earnings Flash (BCPC) Balchem Corporation Posts Q3 Adjusted EPS $1.57 per Share, vs. FactSet Est of $1.54

marketscreener.com report covering Balchem Corporation (BCPC) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟢 CATALYST Stock Titan • 20h ago

Quarterly sales and profit set records at Balchem. Sales reached $290.7 million.

Stock Titan report covering Balchem Corporation (BCPC) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Yahoo Finance • 23h ago

Balchem Corporation (BCPC) Stock Forecasts

Yahoo Finance report covering Balchem Corporation (BCPC) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Seeking Alpha • 1d ago

Balchem Corporation 2026 Q3 - Results - Earnings Call Presentation (NASDAQ:BCPC) 2026-10-26

Seeking Alpha report covering Balchem Corporation (BCPC) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🔴 RISK WATCH StocksToTrade • 1d ago

Balchem Falls 3% After Analyst Cuts Target

StocksToTrade report covering Balchem Corporation (BCPC) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

BCPC Bull vs. Bear Conversation Board — What's Your Call at $169.98?

🐂 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON BCPC 🐻 33% BEARISH CONVICTION

RO RoarDesk_Moderator Roarable Research Desk 🐂 BULLISH 🎯 Target: $201.07 (+18.0%)

📌 Pinned Debate

🔥 Official Bull vs. Bear Debate: Is BCPC (B • RQD 72/100) a Buy at $170.40?

Welcome to the BCPC (Balchem Corporation) Roar Pit. Current RQD Composite is 72/100 (Roarable Buy — Good Risk/Reward) in Major Chemicals. Bulls point to capital efficiency (14.0% ROIC), while bears focus on valuation multiple compression (35.0x trailing P/E). Pick your side (🐂 Bull or 🐻 Bear) and drop your price target below.

FO ForensicBear Forensic Accounting Watch 🐻 BEARISH 🎯 Target: $131.21 (-23.0%)

Spot @ $170.40

Pump the brakes on BCPC — check the valuation vs. margin headwinds

Everyone in here is repeating the bull case on BCPC, but look at what you are paying: 35.0x trailing P/E with 35.7% gross margins. Unless Balchem Corporation expands free cash flow yield next quarter, I would rather wait for a pullback closer to the 200-day moving average before touching this.

SI SiliconVal_Bull Verified K Arena Trader 🐂 BULLISH 🎯 Target: $197.66 (+16.0%)

Spot @ $170.40

BCPC cash flow & RQD setup is being underpriced by the Street here

Looking at the 5-pillar RQD breakdown on BCPC, the market is fixating on short-term headline noise in Major Chemicals and ignoring the balance sheet and cash flow trajectory. At $170.40 (52-wk range $147.18 - $183.90), any beat on forward guidance forces shorts and underweight funds to chase.